New York adviser sentenced to six months for insider trading

Tibor Klein also will pay $20,000 fine for trading on 2010 Pfizer acquisition.
FEB 13, 2018

Tibor Klein, a Long Island, N.Y., investment adviser, was sentenced to six months in prison on Monday after pleading guilty to insider trading in connection with Pfizer Inc's $3.6 billion acquisition of King Pharmaceuticals Inc. in 2010. U.S. District Judge Joan Azrack sentenced Mr. Klein, 44, in federal court in Brooklyn, N.Y., according to a Reuters report. Last July, Mr. Klein had pleaded guilty to one count of conspiracy to commit securities fraud. Mr. Klein, the founder of Valley Stream, N.Y.-based Klein Financial Services, also was sentenced to six months of house arrest and 250 hours of community service, according to Reuters, and ordered to forfeit $37,225 and pay a $20,000 fine. The government said Mr. Klein learned about the deal from Robert Schulman, then a partner at the law firm Hunton & Williams in Washington, who had represented King Pharmaceuticals. Mr. Klein purchased shares in King for himself, Mr. Schulman and clients, and informed a friend, Michael Shechtman, a Florida stockbroker, about the deal. Prosecutors say the insider trading resulted in more than $400,000 of overall illegal profit. Mr. Schulman, of McLean, Va., was convicted of insider trading last March. Mr. Shechtman, a former broker at Ameriprise, pleaded guilty in Brooklyn in November 2014 to conspiracy and has cooperated with prosecutors. He has not been sentenced. The Securities and Exchange Commission filed related civil charges against Mr. Klein and Mr. Shechtman in September 2013, but that case was put on hold until the criminal case was resolved.

Latest News

The 2025 InvestmentNews Awards Excellence Awardees revealed
The 2025 InvestmentNews Awards Excellence Awardees revealed

From outstanding individuals to innovative organizations, find out who made the final shortlist for top honors at the IN awards, now in its second year.

Top RIA Cresset warns of 'inevitable' recession amid tariff uncertainty
Top RIA Cresset warns of 'inevitable' recession amid tariff uncertainty

Cresset's Susie Cranston is expecting an economic recession, but says her $65 billion RIA sees "great opportunity" to keep investing in a down market.

Edward Jones joins the crowd to sell more alternative investments
Edward Jones joins the crowd to sell more alternative investments

“There’s a big pull to alternative investments right now because of volatility of the stock market,” Kevin Gannon, CEO of Robert A. Stanger & Co., said.

Record RIA M&A activity marks strong start to 2025
Record RIA M&A activity marks strong start to 2025

Sellers shift focus: It's not about succession anymore.

IB+ Data Hub offers strategic edge for U.S. wealth advisors and RIAs advising business clients
IB+ Data Hub offers strategic edge for U.S. wealth advisors and RIAs advising business clients

Platform being adopted by independent-minded advisors who see insurance as a core pillar of their business.

SPONSORED Compliance in real time: Technology's expanding role in RIA oversight

RIAs face rising regulatory pressure in 2025. Forward-looking firms are responding with embedded technology, not more paperwork.

SPONSORED Advisory firms confront crossroads amid historic wealth transfer

As inheritances are set to reshape client portfolios and next-gen heirs demand digital-first experiences, firms are retooling their wealth tech stacks and succession models in real time.